Monthly Archives: September 2024

The Department of Health and Social Care (DHSC) has confirmed that sufficient stock of Quetiapine tablets is now available to meet normal demand. As a result the following  Serious Shortage Protocols, will expire at 23.59pm on Friday 13 September 2024. After this date, any prescriptions for Quetiapine tablets must be dispensed in accordance with the prescription, [...]

The post Expiry of nine Quetiapine SSPs (SSP062-SSP070) appeared first on Community Pharmacy England.

Community Pharmacy England met with 45 MPs and parliamentary staff at the Houses of Parliament earlier this week (Tuesday 10th September 2024) to discuss the critical pressures on community pharmacies and their important role in local healthcare. During the busy event, MPs were shown how residents in their constituencies benefit from pharmacy services including Pharmacy [...]

The post MPs back pharmacies at Parliamentary drop-in event appeared first on Community Pharmacy England.

Today, NHS England has announced that notifications of unplanned temporary suspensions of services (closures) can now be made via the Manage Your Service (MYS) portal. The Terms of Service require NHS community pharmacy owners to have a business continuity plan for temporary suspensions due to illness or other reason beyond their control and to action [...]

The post New MYS route for Temporary Suspensions Notifications appeared first on Community Pharmacy England.

Both the huge potential for expanding the clinical role of pharmacists and a growing concern for community pharmacy’s resources have been recognised in an independent investigation into the NHS. The final report of Lord Darzi’s review of the NHS in England, commissioned by the Secretary of State for Health and Social Care, has concluded that [...]

The post ‘Huge potential’ for community pharmacy recognised in NHS review appeared first on Community Pharmacy England.

MHRA Class 3 Medicines Recall: Evorel Sequi (Theramex HQ UK Ltd) Drug alert number: EL (24)A/41 Date issued: 12 September 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 3 medicines defect information notice for: Evorel Sequi (Theramex HQ UK Ltd) Company name:Theramex HQ UK Ltd Product name: Evorel Sequi, PL 49105/0010 [...]

The post MHRA Class 3 Medicines Recall: Evorel Sequi (Theramex HQ UK Ltd) appeared first on Community Pharmacy England.